Biotech Communications in a Post-COVID World with Megan Prock McGrath PR 360

Megan Prock McGrath is the Managing Director at MacDougall, where she provides clients with corporate communications counsel to help them elevate their voices in the industry. She is passionate about healthcare solutions for today's pressing problems, particularly those designed to lower costs, improve care, and serve vulnerable populations. Here, Megan discusses the impact of the COVID-19 pandemic on the industry, shares insights on effective messaging for clinical trials, and addresses the healthcare issues faced by the LGBTQ+ community.
Key Takeaways:
- COVID-19 increased public awareness of drug development
- Effective messaging for clinical trials
- The LGBTQ+ community faces challenges in healthcare access
Episode Timeline:
1:50    The Impact of COVID-19 on biotech communication
3:30    Is the public more informed about the world of biotech post-COVID?
6:30    Effective messaging for clinical trials
7:15    How to appeal to clinical trial participants
11:20 The challenges of accessing Capital in a bear market
14:15 Healthcare challenges in the LGBTQ+ community
16:40 The controversy surrounding gender-diverse care
20:10 The impact of AI on biotech communication
21:45 AI and ethics

This episode’s guest:

Megan Prock McGrath on LinkedInMacDougall Advisors
Subscribe and leave a 5-star review:
https://pod.link/1496390646
Contact Us!
•            Join the conversation by leaving a comment!
•            Follow us on Facebook, Twitter, Instagram, and LinkedIn!
Thanks for listening!

Hosted on Acast. See acast.com/privacy for more information.